Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensity-Reference-Cited by-同舟云学术

Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensity

Published:1988-06 Issue:6 Volume:56 Page:241-248
ISSN:0006-5242
Container-title:Blut
language:en
Short-container-title:Blut

Author:

Evans William E.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/BF00320282.pdf

Reference29 articles.

1. Bennett CL, Sinkule JA, Schilsky RL, et al. (1987) Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer. Cancer Res 47: 1952?1956

2. Bertino JR (1987) Blood levels of cancer chemotherapeutic agents and clinical outcome. J Clin Oncol 5: 996

3. Bonnadonna C, Valagussa P (1981) Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304: 10?15

4. Borsi J, et al. (1987) Prognostic importance of systemic clearance of methotrexate in childhood ALL. Cancer Chemother Pharmacol 19: 261?264

5. Borsi JD, Moe PJ (1987) Systemic clearance of methotrexate in the prognosis of acute lymphocytic leukemia in children. Cancer 60: 3020?3024

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Body Fat on Population Pharmacokinetics of High‐Dose Methotrexate in Pediatric Patients With Acute Lymphoblastic Leukemia;The Journal of Clinical Pharmacology;2021-01-13

2. Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2020-01

3. Exposure–Response Relationships of Anticancer Agents: Application in Drug Development and Drug Label;Cancer Drug Discovery and Development;2013-11-30

4. Therapeutic drug monitoring of cancer chemotherapy;Journal of Oncology Pharmacy Practice;2007-12

5. A Phase I Trial Defining the Maximum Tolerated Systemic Exposure of Topotecan in Combination with Carboplatin and Etoposide in Extensive Stage Small Cell Lung Cancer;Cancer Investigation;2005-01